Home › NDC Lookup › RxCUI directory › RxCUI 1746527

2.5 ML defibrotide sodium 80 MG/ML Injection — RxCUI 1746527

RxNorm drug concept · Semantic clinical drug
RxCUI 1746527 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1746527
Official name2.5 ML defibrotide sodium 80 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdefibrotide sodium 200 MG per 2.5 ML Injection; defibrotide sodium 200 MG in 2.5 ML Injection
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Defibrotide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Defitelio is used to treat a serious liver complication called hepatic veno-occlusive disease, or VOD — sometimes called sinusoidal obstruction syndrome. It happens when small bloo...
  • What exactly is Defitelio used for, and why does my family member need it?
  • Defitelio is given through an IV line in a hospital — not at home. Each dose is infused slowly over 2 hours, and it's given four times a day, every 6 hours. The minimum treatment c...
  • How is Defitelio given, and how long does treatment last?
📖 Read our full Defibrotide Injection guide →

🕸️ Concept Web — How 2.5 ML defibrotide sodium 80 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2.5 ML defibrotide sodium 80 MG/ML Injection RxCUI 1746527

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Defibrotide 1311089
    • Defibrotide sodium 1746523
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Defitelio 1746528
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Defibrotide Injection 1746526
    • Defibrotide sodium Injection 2645417
    • Defibrotide Injectable Product 1746525
    • Defibrotide sodium Injectable Product 2662625
    • Defibrotide Injection [Defitelio] 1746530
    • Defibrotide sodium Injection [Defitelio] 2658115
    • Defitelio Injectable Product 1746531
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Defibrotide sodium 80 MG/ML SCDC · 1746524
  • Defibrotide Injection SCDF · 1746526
  • Defibrotide sodium Injection SCDFP · 2645417
  • Defibrotide Injectable Product SCDG · 1746525
  • Defibrotide sodium Injectable Product SCDGP · 2662625

Brand-Name Concepts

  • 2.5 ML defibrotide sodium 80 MG/ML Injection [Defitelio] SBD · 1746532
  • Defibrotide sodium 80 MG/ML [Defitelio] SBDC · 1746529
  • Defibrotide Injection [Defitelio] SBDF · 1746530
  • Defibrotide sodium Injection [Defitelio] SBDFP · 2658115
  • Defitelio Injectable Product SBDG · 1746531
  • Defitelio BN · 1746528

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1746527 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68727-0800-01 2.5 mL in 1 VIAL (68727-800-01) DEFITELIO Jazz Pharmaceuticals, Inc. 2016-03-30
68727-0800-02 25 mL in 1 CARTON (68727-800-02) DEFITELIO Jazz Pharmaceuticals, Inc. 2016-03-30
Observed labelers: Jazz Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.